The Kingdom of Bahrain achieves a historical medical milestone
Royal Medical Services–Bahrain Oncology Center has successfully completed the treatment of a sickle cell disease patient using Casgevy, a CRISPR-based gene-editing therapy for bone marrow transplantation. This marks the first successful treatment of its kind outside the United States.

His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister, visited the world’s first sickle cell disease patient outside the United States of America to successfully complete treatment with Casgevy (exagamglogene autotemcel), a CRISPR - based gene-editing therapy using bone marrow transplantation technology - at the Bone Marrow and Stem Cell Transplant Unit at the Royal Medical Services- Bahrain Oncology Center.
HRH Prince Salman bin Hamad highlighted the Kingdom’s commitment to staying at the forefront of scientific advancements and integrating them into treatment and rehabilitation services for Bahrainis, underscoring this as a top priority.
His Royal Highness noted that directing efforts and resources toward this goal will not only enhance citizens’ health and wellbeing but also strengthen the Kingdom’s health sector, in line with the far-reaching vision of His Majesty King Hamad bin Isa Al Khalifa.
HRH Prince Salman bin Hamad reiterated the Kingdom’s commitment to advancing its health sector and delivering world-class health care and medical treatments. His Royal Highness emphasised the importance of strengthening partnerships with specialised international health institutions and organisations to ensure access to the latest medical and treatment technologies.

Other News
Book an Appointment
Our expert teams are ready to support you on your health journey. Contact us today to discover how we can help you achieve and maintain your well-being.
Book Appointment